"O Hospital Ernesto Dornelles é uma instituição de saúde privada, possui 312 leitos e 33 especialidades médicas. Inaugurado no dia 30 de junho de 1962, o HED tem uma tradição de pioneirismo e inovações técnicas, na trajetória da medicina gaúcha e brasileira. Nossa missão é proporcionar assistência integral e qualificada à saúde, buscando ser referência médico hospitalar, através de uma empresa autossustentável."

During the past decade, Hospital Ernesto Dornelles conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 5 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Ernesto Dornelles" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Hospital Moinhos de Vento" with 2 trials sponsored, "BioAge Labs, Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Ernesto Dornelles" #1 collaborator was "BP - A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Brazilian Research in Intensive Care Network (BRICNet)" with 1 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 1 trials as a collaborator, "Hospital Ernesto Dornelles" with 1 trials as a collaborator and "Hospital Israelita Albert Einstein" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Ernesto Dornelles" are "Crohn Disease" (3 trials), "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Acinetobacter Infections" (1 trials) and "Bacteremia" (1 trials). Many other conditions were trialed in "Hospital Ernesto Dornelles" in a lesser frequency.

Most popular intervention types in "Hospital Ernesto Dornelles" are "Drug" (16 trials), "Other" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (4 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Ernesto Dornelles" are 19 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Ernesto Dornelles". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hospital Ernesto Dornelles, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Ernesto Dornelles, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".